Table 1.
E. coli Strains | MIC (mg/L) | ||
---|---|---|---|
TGC | MIN | TETa | |
E. coli 25922 | 0.25 | 0.25 | 1 |
Vector control | 0.5 | 1 | 2 |
tet(X2) | 1 | 4 | 16 |
tet(X3) | 16 | 16 | 128 |
tet(X4) | 16 | 16 | 128 |
H196Lb | 1 | 4 | 32 |
Q197H | 1 | 2 | 32 |
S217A | 2 | 4 | 32 |
S217G | 1 | 2 | 16 |
H279R | 1 | 4 | 16 |
T280V | 2 | 4 | 16 |
T280L | 1 | 4 | 16 |
T280S | 2 | 4 | 16 |
L282S | 4 | 8 | 32 |
E295G | 1 | 4 | 32 |
E295N | 2 | 4 | 32 |
E295D | 1 | 4 | 16 |
K296N | 1 | 2 | 16 |
P297D | 1 | 2 | 8 |
P297S | 1 | 4 | 16 |
I359M | 1 | 4 | 16 |
I359V | 1 | 4 | 32 |
V329L | 2 | 8 | 32 |
V329M | 2 | 8 | 32 |
A339T | 2 | 4 | 32 |
D340N | 1 | 4 | 32 |
V350I | 1 | 4 | 32 |
K351E | 2 | 4 | 32 |
A339T/D340N | 4 | 8 | 64 |
V350I/K351E | 4 | 8 | 64 |
V329L/A339T/D340N | 8 | 8 | 64 |
V329L/V350I/K351E | 4 | 8 | 64 |
V329M/A339T/D340N | 4 | 8 | 128 |
V329M/V350I/K351E | 8 | 16 | 64 |
A339T/D340N/V350I/K351E | 8 | 8 | 64 |
V329L/A339T/D340N/V350I/K351E | 16 | 16 | 128 |
V329M/A339T/D340N/V350I/K351E | 16 | 16 | 64 |
tet(X3)-L329V/T339A/N340D/I350V/E351Kc | 2 | 8 | 64 |
tet(X4)-M329V/T339A/N340D/I350V/E351Kd | 2 | 8 | 64 |
aTET tetracycline, MIN minocycline, TGC tigecycline.
bAll mutants are derived from pBAD18-Tet(X2) by site-directed mutagenesis.
ctet(X3)-L329V/T339A/N340D/I350V/E351K is reverse penta mutant derived from pBAD18-tet(X3).
dtet(X4)-M329V/T339A/N340D/I350V/E351K is reverse penta mutant derived from pBAD18-tet(X4).